Next 10 |
2024-07-01 10:48:16 ET More on S&P 500 Index: Inflation Fears To Shift To Growth Concerns Weekly Market Pulse: The S&P 500 Rules Everything Around Me Nearing Full Froth: A Look Inside The Current Market Bubble Nasdaq, S&P, Dow trade higher as mark...
NEW YORK CITY, NY / ACCESSWIRE / July 1, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE:ELAN). Investors who purchased Elanco securities are encouraged to obtain additi...
2024-07-01 07:00:08 ET David Westenberg from Piper Sandler issued a price target of $16.00 for ELAN on 2024-07-01 06:25:00. The adjusted price target was set to $16.00. At the time of the announcement, ELAN was trading at $14.43. The overall price target consensus is at ...
2024-06-30 05:58:23 ET Summary Elanco Animal Health shares have dropped over 20% due to a delay in the innovative product pipeline, but potential for a recovery remains. The company's divestment of the aqua business at a high sales multiple reduced leverage ratios, improving the o...
MONSEY, N.Y., June 28, 2024 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating whether Elanco Animal Health Incorporated (NYSE:ELAN) (“Elanco”) has violated federal securities laws after the company announced that the U.S. label for its new eczema treatment...
2024-06-27 10:50:00 ET More on Elanco Elanco Animal Health: At Least Fully Valued After Rally Elanco Animal Health (ELAN) Q1 2024 Earnings Call Transcript Elanco Animal Health Incorporated 2024 Q1 - Results - Earnings Call Presentation Elanco wins FDA nod for...
Elanco Provides Innovation Update PR Newswire Major technical sections complete for Zenrelia, with FDA final approval on track for late in third quarter of 2024; updates on differentiation and safety Final FDA approval for Credelio Quattro now expected in the fo...
NORTHAMPTON, MA / ACCESSWIRE / June 26, 2024 / Elanco Farmers will be able to add Bovaer-a methane-reducing ingredient-to dairy cows' feed, potentially reducing emissions by 30%. Originally published by Fast Company In May, the Food and Drug Administration said Bovaer met safety and ef...
Elanco to Participate in Goldman Sachs 45th Annual Global Healthcare Conference PR Newswire GREENFIELD, Ind. , June 6, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will attend the Goldman Sachs 45th Annual Global Healthcare Conference, Ju...
2024-06-05 14:43:16 ET Summary The stock of Elanco Animal Health Incorporated has more than doubled off its recent lows in late October. Product launches should boost revenue growth from 2% to 3% in FY2024 to 4% to 5% in FY2025. It should be noted that the company carries a go...
News, Short Squeeze, Breakout and More Instantly...
Elanco Animal Health Incorporated Company Name:
ELAN Stock Symbol:
NYSE Market:
Elanco Animal Health Incorporated Website:
NEW YORK CITY, NY / ACCESSWIRE / July 1, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE:ELAN). Investors who purchased Elanco securities are encouraged to obtain additi...
2024-07-01 07:00:08 ET David Westenberg from Piper Sandler issued a price target of $16.00 for ELAN on 2024-07-01 06:25:00. The adjusted price target was set to $16.00. At the time of the announcement, ELAN was trading at $14.43. The overall price target consensus is at ...
Elanco Provides Innovation Update PR Newswire Major technical sections complete for Zenrelia, with FDA final approval on track for late in third quarter of 2024; updates on differentiation and safety Final FDA approval for Credelio Quattro now expected in the fo...